TABLE OF CONTENTS
| | | | Volume 32, Issue 6 (February 2013) | | In this issue Review Original Articles Short Communication Corrigenda Retraction
Also new AOP
| | | | | Advertisement | | | | | Review | Top | | Anti-oncogenic potential of the eIF4E-binding proteinsY Martineau, R Azar, C Bousquet and S Pyronnet Oncogene 2013 32: 671-677; advance online publication, April 16, 2012; 10.1038/onc.2012.116 Abstract | Full Text | | Original Articles | Top | | Insulin-like growth factor-I regulates GPER expression and function in cancer cellsP De Marco, V Bartella, A Vivacqua, R Lappano, M F Santolla, A Morcavallo, V Pezzi, A Belfiore and M Maggiolini Oncogene 2013 32: 678-688; advance online publication, March 19, 2012; 10.1038/onc.2012.97 Abstract | Full Text | | | | The receptor tyrosine kinase Axl is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic targetJ D Paccez, G J Vasques, R G Correa, J F Vasconcellos, K Duncan, X Gu, M Bhasin, T A Libermann and L F Zerbini Oncogene 2013 32: 689-698; advance online publication, March 12, 2012; 10.1038/onc.2012.89 Abstract | Full Text | | | | The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cellsS Galavotti, S Bartesaghi, D Faccenda, M Shaked-Rabi, S Sanzone, A McEvoy, D Dinsdale, F Condorelli, S Brandner, M Campanella, R Grose, C Jones and P Salomoni Oncogene 2013 32: 699-712; advance online publication, April 23, 2012; 10.1038/onc.2012.111 Abstract | Full Text | | | | Phosphorylation of Mps1 by BRAFV600E prevents Mps1 degradation and contributes to chromosome instability in melanomaJ Liu, X Cheng, Y Zhang, S Li, H Cui, L Zhang, R Shi, Z Zhao, C He, C Wang, H Zhao, C Zhang, H A Fisk, T M Guadagno and Y Cui Oncogene 2013 32: 713-723; advance online publication, March 19, 2012; 10.1038/onc.2012.94 Abstract | Full Text | | | | Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungsV Stresing, E Baltziskueta, N Rubio, J Blanco, MaC Arriba, J Valls, M Janier, P Clézardin, R Sanz-Pamplona, C Nieva, M Marro, P Dmitri and A Sierra Oncogene 2013 32: 724-735; advance online publication, March 19, 2012; 10.1038/onc.2012.93 Abstract | Full Text | | | | The chemotherapeutic agent paclitaxel inhibits autophagy through two distinct mechanisms that regulate apoptosisR A Veldhoen, S L Banman, D R Hemmerling, R Odsen, T Simmen, A J Simmonds, D A Underhill and I S Goping Oncogene 2013 32: 736-746; advance online publication, March 19, 2012; 10.1038/onc.2012.92 Abstract | Full Text | | | | Autocrine IL-1β-TRAF6 signalling promotes squamous cell carcinoma invasion through paracrine TNFα signalling to carcinoma-associated fibroblastsS I Chaudhry, S Hooper, E Nye, P Williamson, K Harrington and E Sahai Oncogene 2013 32: 747-758; advance online publication, March 26, 2012; 10.1038/onc.2012.91 Abstract | Full Text | | | | Yes and Lyn play a role in nuclear translocation of the epidermal growth factor receptorM Iida, T M Brand, D A Campbell, C Li and D L Wheeler Oncogene 2013 32: 759-767; advance online publication, March 19, 2012; 10.1038/onc.2012.90 Abstract | Full Text | | | | PIK3CA mutation spectrum in urothelial carcinoma reflects cell context-dependent signaling and phenotypic outputsR L Ross, J M Askham and M A Knowles Oncogene 2013 32: 768-776; advance online publication, March 19, 2012; 10.1038/onc.2012.87 Abstract | Full Text | | | | Raf activation by Ras and promotion of cellular metastasis require phosphorylation of prohibitin in the raft domain of the plasma membraneC-F Chiu, M-Y Ho, J-M Peng, S-W Hung, W-H Lee, C-M Liang and S-M Liang Oncogene 2013 32: 777-787; advance online publication, March 12, 2012; 10.1038/onc.2012.86 Abstract | Full Text | | | | A potent Chk1 inhibitor is selectively cytotoxic in melanomas with high levels of replicative stressK Brooks, V Oakes, B Edwards, M Ranall, P Leo, S Pavey, A Pinder, H Beamish, P Mukhopadhyay, D Lambie and B Gabrielli Oncogene 2013 32: 788-796; advance online publication, March 5, 2012; 10.1038/onc.2012.72 Abstract | Full Text | | Short Communication | Top | | miR-143 regulates hexokinase 2 expression in cancer cellsA Peschiaroli, A Giacobbe, A Formosa, E K Markert, L Bongiorno-Borbone, A J Levine, E Candi, A D'Alessandro, L Zolla, A Finazzi Agrò and G Melino Oncogene 2013 32: 797-802; advance online publication, April 2, 2012; 10.1038/onc.2012.100 Abstract | Full Text | | Corrigenda | Top | | ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemiaX Agirre, J Román-Gómez, A Jiménez-Velasco, L Garate, C Montiel-Duarte, G Navarro, I Vázquez, M Zalacain, M J Calasanz, A Heiniger, A Torres, J D Minna and F Prósper Oncogene 2013 32: 803; 10.1038/onc.2012.593 Full Text | | | | Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungsV Stresing, E Baltziskueta, N Rubio, J Blanco, M C Arriba, J Valls, M Janier, P Clézardin, R Sanz-Pamplona, C Nieva, M Marro, D Petrov and A Sierra Oncogene 2013 32: 804; 10.1038/onc.2012.473 Full Text | | Retraction | Top | | Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemiaJ Roman-Gomez, A Jimenez-Velasco, X Agirre, F Cervantes, J Sanchez, L Garate, M Barrios, J A Castillejo, G Navarro, D Colomer, F Prosper, A Heiniger and A Torres Oncogene 2013 32: 804; 10.1038/onc.2012.592 Full Text | | | | | | | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | |
| | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. | | |
|
|
No comments:
Post a Comment